These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35332652)
1. Cirrhotic cardiomyopathy: Appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes. Spann A; Coe C; Ajayi T; Montgomery G; Shwetar M; Oje A; Annis J; Slaughter JC; Alexopoulos S; Brittain E; Izzy M Liver Transpl; 2022 Aug; 28(8):1321-1331. PubMed ID: 35332652 [TBL] [Abstract][Full Text] [Related]
2. Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria. Izzy M; Soldatova A; Sun X; Angirekula M; Mara K; Lin G; Watt KD Liver Transpl; 2021 Jun; 27(6):876-886. PubMed ID: 33533556 [TBL] [Abstract][Full Text] [Related]
3. Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant. Ali SA; Arman HE; Shamseddeen H; Elsner N; Elsemesmani H; Johnson S; Zenisek J; Khemka A; Jarori U; Patidar KR; Orman E; Kubal C; Frick K J Cardiol; 2023 Aug; 82(2):113-121. PubMed ID: 37085028 [TBL] [Abstract][Full Text] [Related]
4. Impact of Cirrhotic Cardiomyopathy Diagnosed According to Different Criteria on Patients with Cirrhosis Awaiting Liver Transplantation: A Retrospective Cohort Study. Singh AD; Ford A; Lyu R; Layoun H; Harb SC; Fares M; Carey WD Dig Dis Sci; 2022 Nov; 67(11):5315-5326. PubMed ID: 35150344 [TBL] [Abstract][Full Text] [Related]
8. Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation. Rimbaș RC; Rimbas M; Chitroceanu AM; Luchian LM; Pop C; Vinereanu D J Gastrointestin Liver Dis; 2020 Dec; 29(4):665-675. PubMed ID: 33331343 [TBL] [Abstract][Full Text] [Related]
9. Factors Associated With Major Adverse Cardiovascular Events After Liver Transplantation Among a National Sample. VanWagner LB; Serper M; Kang R; Levitsky J; Hohmann S; Abecassis M; Skaro A; Lloyd-Jones DM Am J Transplant; 2016 Sep; 16(9):2684-94. PubMed ID: 26946333 [TBL] [Abstract][Full Text] [Related]
17. Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander. Izzy M; Oh J; Watt KD Hepatology; 2018 Nov; 68(5):2008-2015. PubMed ID: 29672903 [TBL] [Abstract][Full Text] [Related]
18. Markedly prolonged QTc interval in end-stage liver disease and risk of 30-day cardiovascular event after liver transplant. Kim KS; Kwon HM; Jung KW; Sang BH; Moon YJ; Kim B; Jun IG; Song JG; Hwang GS J Gastroenterol Hepatol; 2021 Mar; 36(3):758-766. PubMed ID: 32804412 [TBL] [Abstract][Full Text] [Related]
19. Cirrhotic cardiomyopathy influences clinical outcomes and enhances performance of conventional risk prediction models in acute-on-chronic liver failure with severe sepsis. Kajal K; Premkumar M; Izzy M; Kulkarni AV; Duseja AK; Divyaveer S; Loganathan S; Sihag B; Gupta A; Bahl A; Rathi S; Taneja S; De A; Verma N; Sharma N; Kaur H; Zohmangaihi D; Kumar V; Bhujade H; Chaluvashetty SB; Kalra N Aliment Pharmacol Ther; 2023 Nov; 58(9):903-919. PubMed ID: 37688403 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Liver Graft Recipient Workup in Predicting of Early Cardiovascular Events During Liver Transplantation: A Single-Center Experience. Raszeja-Wyszomirska J; Glowczynska R; Kostrzewa K; Janik M; Zygmunt M; Zborowska H; Krawczyk M; Niewinski G; Galas M; Krawczyk M; Zieniewicz K; Milkiewicz P; Opolski G Transplant Proc; 2018 Sep; 50(7):1997-2001. PubMed ID: 30177096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]